Personalized chemo shows promise against rare sarcomas
Disease control
Completed
This study tested whether giving chemotherapy based on the specific type of soft tissue sarcoma works better than standard chemotherapy. About 550 adults with high-risk sarcoma in their arms, legs, or trunk took part. The goal was to see if the tailored approach could delay or pr…
Phase: PHASE3 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated May 17, 2026 02:44 UTC